AVE.AX · AVECHO BIOTECHNOLOGY LIMITED
Australia · RS rating 47 · As of 2026-10-14
| Price | 0.01 AUD |
|---|---|
| 1-day change | -23.5% |
| RS rating (overall / 1M / 3M / 12M) | 47 / 3 / 7 / 95 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 40 / 15 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +48.0% |
| Market cap (USD) | $43.0M |